Transmissibility of 1918 pandemic influenza

The 1918 influenza pandemic killed 20–40 million people worldwide, and is seen as a worst-case scenario for pandemic planning. Like other pandemic influenza strains, the 1918 A/H1N1 strain spread extremely rapidly. A measure of transmissibility and of the stringency of control measures required to stop an epidemic is the reproductive number, which is the number of secondary cases produced by each primary case. Here we obtained an estimate of the reproductive number for 1918 influenza by fitting a deterministic SEIR (susceptible-exposed-infectious-recovered) model to pneumonia and influenza death epidemic curves from 45 US cities: the median value is less than three. The estimated proportion of the population with A/H1N1 immunity before September 1918 implies a median basic reproductive number of less than four. These results strongly suggest that the reproductive number for 1918 pandemic influenza is not large relative to many other infectious diseases. In theory, a similar novel influenza subtype could be controlled. But because influenza is frequently transmitted before a specific diagnosis is possible and there is a dearth of global antiviral and vaccine stores, aggressive transmission reducing measures will probably be required.

[1]  W. R. Hand.  Johns Hopkins Hospital Reports , 1894, Glasgow Medical Journal.

[2]  L. L. Stanley.  Influenza at San Quentin Prison, California , 1919 .

[3]  W. H. Frost.  Statistics of Influenza Morbidity: With Special Reference to Certain Factors in Case Incidence and Case Fatality , 1920 .

[4]  Mortality rates, 1910-1920 : with population of the federal censuses of 1910 and 1920 and intercensal estimates of population , 1923 .

[5]  E. O. Jordan,et al.  Epidemic Influenza. A Survey. , 1927 .

[6]  S. D. Collins,et al.  Mortality from Influenza and Pneumonia in 50 Large Cities of the United States, 1910-1929. , 1930 .

[7]  D. W. Henderson,et al.  Observations on the prophylaxis of experimental pulmonary anthrax in the monkey , 1956, Journal of Hygiene.

[8]  J. M. Ross.  The pathogenesis of anthrax following the administration of spores by the respiratory route , 1957 .

[9]  S. Shapiro.  THE EPIDEMIOLOGY OF INFLUENZA. , 1965, Eye, ear, nose & throat monthly.

[10]  C C Spicer,et al.  Epidemic influenza in Greater London , 1984, Journal of Hygiene.

[11]  L. A. Rvachev,et al.  A mathematical model for the global spread of influenza , 1985 .

[12]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[13]  K. D. Patterson,et al.  The geography and mortality of the 1918 influenza pandemic. , 1991, Bulletin of the history of medicine.

[14]  J. Ezzell,et al.  Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.

[15]  P. Kaye.  Infectious diseases of humans: Dynamics and control , 1993 .

[16]  A Watson,et al.  Information on which to base assessments of risk from environments contaminated with anthrax spores , 1994, Epidemiology and Infection.

[17]  M. Hugh-jones,et al.  The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.

[18]  M. Meltzer,et al.  The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? , 1997, Emerging infectious diseases.

[19]  L. Simonsen,et al.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.

[20]  Philip K. Russell,et al.  Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.

[21]  A. Friedlander.  Anthrax: clinical features, pathogenesis, and potential biological warfare threat. , 2000, Current clinical topics in infectious diseases.

[22]  Fried Am.  Anthrax: clinical features, pathogenesis, and potential biological warfare threat. , 2000 .

[23]  C. P. Quinn,et al.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. , 2001, Emerging infectious diseases.

[24]  Lee L. Zwanziger,et al.  The Anthrax Vaccine. Is It Safe? Does It Work? , 2002 .

[25]  R. Brookmeyer,et al.  Prevention of Inhalational Anthrax in the U.S. Outbreak , 2002, Science.

[26]  Jerome Hauer,et al.  Anthrax as a biological weapon, 2002: updated recommendations for management. , 2002, JAMA.

[27]  Charles N Haas,et al.  On the Risk of Mortality to Primates Exposed to Anthrax Spores , 2002, Risk analysis : an official publication of the Society for Risk Analysis.

[28]  David L. Craft,et al.  Emergency response to a smallpox attack: The case for mass vaccination , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  A. Nizam,et al.  Containing Bioterrorist Smallpox , 2002, Science.

[30]  Elizabeth R. Zell,et al.  Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence , 2002, Emerging infectious diseases.

[31]  J. Gog,et al.  Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Fraser,et al.  Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions , 2003, Science.

[33]  R. Webster,et al.  Are We Ready for Pandemic Influenza? , 2003, Science.

[34]  J. Robins,et al.  Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.

[35]  I. Longini,et al.  The critical vaccination fraction for heterogeneous epidemic models. , 2003, Mathematical biosciences.

[36]  N. Ferguson,et al.  Planning for smallpox outbreaks , 2003, Nature.

[37]  Sally C Morton,et al.  A model for a smallpox-vaccination policy. , 2003, The New England journal of medicine.

[38]  R. Brookmeyer,et al.  Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Wallinga,et al.  Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures , 2004, American journal of epidemiology.

[40]  C. Fraser,et al.  Factors that make an infectious disease outbreak controllable. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Nizam,et al.  Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.